[Therapy with opioids in liver or renal failure].

医学 丙氧芬 喷他佐辛 药理学 葡萄糖醛酸化 曲马多 吗啡 类阿片 药代动力学 麻醉 氢吗啡酮 美沙酮 止痛药 内科学 化学 酶 受体 微粒体 生物化学
作者
Irmgard Tegeder,Gerd Geißlinger,Jörn Lötsch
出处
期刊:PubMed [National Institutes of Health]
卷期号:13 (3): 183-195 被引量:23
标识
DOI:10.1007/s004829900019
摘要

In patients with renal or hepatic failure, the pharmacokinetics of opioids may be affected in several ways, leading to the necessity to correct the dose. The liver is the major site for biotransformation of most opioids. The major metabolic pathway is oxidation. Exceptions to this are morphine and buprenorphine, which undergo primarily glucuronidation, and remifentanil which is cleared by esther hydrolysis. The hydrophilic metabolites are predominantly excreted by the kidneys and may accumulate in patients with renal insufficiency. Some metabolites such as morphine-6-glucuronide (M6G) or normeperidine are active opioid agonists. With high concentrations they may cause narcotic effects or respiratory depression. In addition, special risks are known for normepridine that has been shown to exert neurotoxic effects with the risk of seizures. Few cases of respiratory depression following the administration of codeine, dihydrocodeine and tramdol have been reported. The elimination half-life of these drugs was prolonged. Lastly, the disposition of methadone, buprenorphine, fentanyl, sufentanyl and remifentanil appears to be unaffected in renal failure. In patients with hepatic cirrhosis it has been shown that oxidation of opioids is reduced, resulting in a decreased drug clearance (meperidine, propoxyphene, pentazocine, tramadol and alfentanil) and increased oral bioavailability due to reduced first-pass metabolism (meperidine, propoxyphene, pentazocine, dihydrocodeine). Although glucuronidation is thought to be less affected in liver cirrhosis, the clearance of morphine was found to be decreased and its oral bioavailability increased. The consequence of reduced drug metabolism is the risk of accumulation in the body, especially with repeated administrations. As for patients with renal failure, special risks are known for meperidine with potential accumulation of normeperidine, which can cause seizures, and for propoxyphene for which several cases of hepatotoxicity have been reported. On the other hand, the analgesic activity of codeine and tilidine depends on transformation into the active metabolites, morphine and nortilidine. In the case of reduced metabolism in chronic liver disease, the analgesic action of these drugs may be compromised. Lastly, the disposition of a few opioids, such as fentanyl, sufentanil, and remifentanil, appears to be unaffected in liver disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
路过发布了新的文献求助10
刚刚
quan完成签到,获得积分20
刚刚
qihaiqianqiu发布了新的文献求助10
刚刚
bubble发布了新的文献求助10
刚刚
WY发布了新的文献求助10
1秒前
wnn完成签到,获得积分10
1秒前
3315152548发布了新的文献求助10
1秒前
1秒前
synt完成签到,获得积分10
1秒前
星辰大海的应助被jackmilton采纳,获得10
1秒前
小二郎的应助被傲娇寄凡采纳,获得10
1秒前
Connie完成签到,获得积分10
1秒前
积极的曲奇完成签到,获得积分10
2秒前
Eidden_Zhang发布了新的文献求助10
2秒前
2秒前
wanci的应助被王子采纳,获得10
3秒前
小k发布了新的文献求助10
3秒前
Betty驳回了所所的应助
3秒前
C66完成签到 ,获得积分10
3秒前
yeziio完成签到,获得积分10
3秒前
池东漾完成签到 ,获得积分10
3秒前
Duolalala发布了新的文献求助10
3秒前
CipherSage的应助被主任采纳,获得10
4秒前
丘比特的应助被李梦晓采纳,获得10
4秒前
4秒前
joe驳回了椰子云的应助
4秒前
叼得一发布了新的文献求助10
4秒前
5秒前
王多肉完成签到,获得积分10
5秒前
5秒前
阿赵完成签到,获得积分10
5秒前
拼搏向上发布了新的文献求助200
5秒前
Samuel发布了新的文献求助10
5秒前
轻松的老鼠完成签到,获得积分10
6秒前
仪式感发布了新的文献求助10
6秒前
6秒前
SODAPIE完成签到,获得积分10
6秒前
6秒前
骑猪砍毛驴完成签到,获得积分10
6秒前
秋分前完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159929
求助须知:如何正确求助?哪些是违规求助? 9555266
关于积分的说明 21726335
捐赠科研通 7749807
什么是DOI,文献DOI怎么找? 3427310
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471654